15 Best Multibagger Stocks to Invest in Right Now

Page 7 of 14

8. Precigen Inc. (NASDAQ:PGEN)

Market Cap: $1.3 Billion

Price Return over 1-Year: 370%

Potential Upside: 85%

Number of Hedge Fund Holders: 16

Precigen Inc. (NASDAQ:PGEN) is one of the best multibagger stocks to invest in right now. Among the company’s proprietary therapeutic platforms, its UltraCAR-T platform offers a differentiated approach to CAR-T treatment, aiming for faster manufacturing and potentially improved safety profiles. The company has multiple candidates progressing through clinical trials, which are being used to build a robust pipeline that addresses significant unmet medical needs.

Precigen Inc.’s (NASDAQ:PGEN) stock is up over 300% year-to-date. Its share price has doubled since mid-August after the successful FDA approval of its Papzimeos therapy, which is the first and only approved treatment for adults with recurrent respiratory papillomatosis.

The approval was seen as highly favourable by the street. Following the news, analysts from JPMorgan had upgraded the stock to Neutral from Underweight, citing the removal of a major overhang. Analysts from Cantor Fitzgerald and H.C. Wainwright had also reiterated their Buy ratings.

For H.C. Wainwright’s Swayampakula Ramakanth, the approval came earlier than expected and covers a broad indication in recurrent respiratory papillomatosis, targeting roughly 27,000 U.S. adults. With Q4 2025 sales projected at $15 million and a focused launch strategy, Ramakanth sees meaningful commercial potential despite regulatory and execution risks.

Precigen Inc. (NASDAQ:PGEN) is a biopharmaceutical company that develops gene and cellular therapies, with a focus on immuno-oncology, autoimmune disorders, and infectious diseases.

Page 7 of 14